What are the main concerns of choosing CTMS and TMF during Brexit and how Flex Databases fixes them?

Nov 19, 2019

Many questions arise about Brexit, and whoever works in the clinical trials industry in the UK or with the UK are having many concerns now – nothing is clear about the final conditions.

Here is a clarification of the most frequent concerns and how Flex Databases fixes them:

  1. Regulatory alignment

In any Brexit case, we, as a provider, and our clients will still be compliant with existing regulations. We are sure it won’t take both sides a lot of time to adapt to new ones when there are any announced.

As a global company, we provide software to customers all over the world, who report to many regulators and follow different laws. We follow:

  • ICH Good Clinical Practice as our main guideline
  • FDA 21 CFR Part 11
  • EudraLex Vol. 4 GMP Annex 11
  • Guideline on the content, management and archiving of the clinical trial master file Good Manufacturing Practice
  • Good Pharmacovigilance Practice
  • etc.

To ensure and evidence regulatory compliance, we perform system validation during the whole development lifecycle of each new version and complete Compliance Assessments. Our validation methodology is based on GAMP® 5 guidance.

The release of every new system version comes along with updated validation documents according to the risk-based approach proclaimed by industry standards.

2. Data storage

With any Brexit scenario, we can offer a suitable location for secure data storage.

Flex Databases system is cloud-based, and all the data is stored on servers in various Data Centers in different countries. We have a list of approved Data Centers according to our SOPs, and location of servers and backups are agreed and reflected in the Service Level Agreement. Generally, Data Center location depends on the Client’s requirement.

3. Data protection

Eight years of being a part of the global clinical trials industry help us to pre-solve some of the issues such a comprehensive process as Brexit may bring. We are prepared to act fast and efficient when the final deal or no-deal conditions are given and make everything the best way for our customers.

Our security policy allows us to adhere to the following standards and regulations, demonstrating our commitment to customers’ security and privacy:

  • 21 CFR Part 11
  • GDPR

To know more, check out our Data Protection Statement and Data Protection Considerations.

Do you have any other concerns considering picking an eClinical system during or after Brexit? Share it with us through contact@flexdatabases.com – we will be glad to answer them!

More about our product

AI validation for life sciences – a unique challenge of dynamic nature

What aspects need validation to ensure confidence in AI-driven processes, and is it possible to achieve 100% certainty?

Learn more
how we implenented eTMF
How we implemented eTMF & developed SOPs in 3 weeks for iRenix

And here’s the twist – while iRenix was laser-focused on their operations and study start-up processes, we rolled up our sleeves to deliver a full-on, turn-key eTMF setup from scratch.

Learn more
TMF Quality Review 2.0
TMF Quality Review 2.0 

Periodic TMF reviews automatically documented. Quality and completeness under control!

Learn more
Archiving eTMF for 25 years
Archiving eTMF for 25 years? Secure, accessible, and compliant with Flex Databases 

Flex Databases offers a solution for all your archiving needs.

Learn more

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.